Literature DB >> 7675229

Emotional facial imagery, perception, and expression in Parkinson's disease.

D H Jacobs1, J Shuren, D Bowers, K M Heilman.   

Abstract

Patients with Parkinson's disease (PD) may be impaired at expressing emotional faces and perceiving emotional facial affect. We tested the hypothesis that patients with PD may be impaired at imaging emotional faces. We first compared 12 patients with PD and 30 control subjects on perceptual and imagery tasks. Patients were significantly impaired on a task of emotional facial imagery but not on a control task of object imagery. Patients were also impaired on a task of perceiving emotional faces. Subsequently, we found that PD patients were impaired relative to controls on making emotional faces. Performance on both the perceptual and motor tasks of facial expression significantly correlated with performance on the emotional facial imagery task. We suggest that the basal ganglia, together with the right hemisphere, are part of a neural network subserving emotional facial tasks.

Entities:  

Mesh:

Year:  1995        PMID: 7675229     DOI: 10.1212/wnl.45.9.1696

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.

Authors:  Alessandro Tessitore; Ahmad R Hariri; Francesco Fera; William G Smith; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger; Venkata S Mattay
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Fear fosters flight: a mechanism for fear contagion when perceiving emotion expressed by a whole body.

Authors:  Beatrice de Gelder; Josh Snyder; Doug Greve; George Gerard; Nouchine Hadjikhani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

3.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

4.  Startle reflex hyporeactivity in Parkinson's disease: an emotion-specific or arousal-modulated deficit?

Authors:  K M Miller; M S Okun; M Marsiske; E B Fennell; D Bowers
Journal:  Neuropsychologia       Date:  2009-03-13       Impact factor: 3.139

5.  Increased anxiety-like behavior following circuit-specific catecholamine denervation in mice.

Authors:  Sara Ferrazzo; Ozge Gunduz-Cinar; Nadia Stefanova; Gabrielle A Pollack; Andrew Holmes; Claudia Schmuckermair; Francesco Ferraguti
Journal:  Neurobiol Dis       Date:  2019-01-21       Impact factor: 5.996

6.  Connectivity of the subthalamic nucleus and globus pallidus pars interna to regions within the speech network: a meta-analytic connectivity study.

Authors:  Jordan L Manes; Amy L Parkinson; Charles R Larson; Jeremy D Greenlee; Simon B Eickhoff; Daniel M Corcos; Donald A Robin
Journal:  Hum Brain Mapp       Date:  2013-11-25       Impact factor: 5.038

Review 7.  Parkinson's disease as a disconnection syndrome.

Authors:  Alice Cronin-Golomb
Journal:  Neuropsychol Rev       Date:  2010-04-10       Impact factor: 7.444

8.  Recognition of emotions from visual and prosodic cues in Parkinson's disease.

Authors:  Alessandra Ariatti; Francesca Benuzzi; Paolo Nichelli
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

9.  Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches.

Authors:  Lucia Ricciardi; Paola Baggio; Diego Ricciardi; Bruno Morabito; Massimiliano Pomponi; Anna Rita Bentivoglio; Roberto Bernabei; Roberto Maestri; Giuseppe Frazzitta; Daniele Volpe
Journal:  Neurol Sci       Date:  2015-11-21       Impact factor: 3.307

10.  Not on the face alone: perception of contextualized face expressions in Huntington's disease.

Authors:  Hillel Aviezer; Shlomo Bentin; Ran R Hassin; Wendy S Meschino; Jeanne Kennedy; Sonya Grewal; Sherali Esmail; Sharon Cohen; Morris Moscovitch
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.